ALX Oncology Holdings Inc Q2 2026 Earnings: Beat on EPS with 24% Positive Surprise
ALX Oncology Holdings Inc (NASDAQ: ALXO) delivered a better-than-expected earnings performance for Q2 2026, reporting an adjusted loss per share of $0.17 c...
Category: Earnings
1stdibs.Com Inc Q2 2026 Earnings: Miss on Both EPS and Revenue
1stdibs.Com Inc (DIBS) reported a disappointing second quarter 2026, missing analyst expectations on both earnings per share and revenue. The…
TOMI Environmental Solutions Inc Q2 2026 Earnings: Mixed Results with EPS Beat, Revenue Miss
TOMI Environmental Solutions Inc (TOMZ) delivered mixed second-quarter 2026 results, meeting earnings expectations while falling short on revenue targets. ...
Entera Bio Ltd Q2 2026 Earnings: Beat on EPS with 54% Positive Surprise
Entera Bio Ltd (NASDAQ: ENTX) delivered a significant earnings beat in its Q2 2026 results, reporting an adjusted loss per…
Interface Inc Q2 2026 Earnings: Beat on EPS with $0.41 vs $0.34 Expected
Interface Inc (TILE) delivered a strong earnings beat in Q2 2026, reporting earnings per share of $0.41 versus analyst estimates…
ALLR Reports Earnings Tomorrow: What to Expect
Allarity Therapeutics reports Q1 2026 earnings May 9th with analysts expecting a $0.22 EPS loss. Focus on clinical progress, cash…
Intensity Therapeutics Inc Q2 2026 Earnings: Beat on EPS with Smaller Loss Than Expected
Intensity Therapeutics Inc (INTS) reported second-quarter 2026 earnings that beat analyst expectations, posting a loss of $0.96 per share compared…
Turning Point Brands Inc Q2 2026 Earnings: Beat on Revenue and EPS
Turning Point Brands Inc (TPB) delivered a solid earnings beat for Q2 2026, reporting adjusted earnings per share of $0.76…
GCI Liberty Inc Q2 2026 Earnings: Miss on Both EPS and Revenue
GCI Liberty Inc (GLIBA) delivered disappointing second-quarter 2026 results, reporting earnings per share of $0.45 versus analyst expectations of $1.25,…
MarketWise Inc Q2 2026 Earnings: Miss on Both Revenue and EPS
MarketWise Inc (MKTW) reported a significant earnings miss for Q2 2026, posting a loss of $0.23 per share against analyst…